KELLEY HAWKINS: Open Payments
NPI 1801026182 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,634 in 126 payments from 21 companies in 2025. Trend: 2023 $1,525 · 2024 $1,725 · 2025 $2,634
Food & beverage: $2,578Education: $56
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 33 | $669 |
| GENZYME CORPORATION | 19 | $384 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $270 |
| Novartis Pharmaceuticals Corporation | 13 | $222 |
| Pharming Healthcare, Inc. | 5 | $114 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| AstraZeneca Pharmaceuticals LP | 3 | $96 |
| Ionis Pharmaceuticals, Inc. | 4 | $89 |
| Amgen Inc. | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
Products named: DUPIXENT, Hizentra, NEFFY, Haegarda, Andembry, TEZSPIRE, RUCONEST, Rhapsido.
Industry payments across KY — which companies pay providers there.
